C-Peptide and Vascular Complications in Type 2 Diabetic Subjects

C-Peptide and Vascular Complications in Type 2 Diabetic Subjects

Bibliographic Details
Main Author:	Seok Man Son
Format:	Article
Language:	English
Published:	Korean Diabetes Association 2012-10-01
Series:	Diabetes & Metabolism Journal
Online Access:	http://e-dmj.org/Synapse/Data/PDFData/2004DMJ/dmj-36-345.pdf

Similar Items

Reactive Oxygen and Nitrogen Species in Pathogenesis of Vascular Complications of Diabetes
by: Seok Man Son
Published: (2012-06-01)

An Association of Fasting C-Peptide Levels and Vascular Complications in Chronic Type 2 Diabetes Mellitus Patients
by: T Thippeswamy, et al.
Published: (2021-02-01)

RAGE-mediated inflammation, type 2 diabetes and diabetic vascular complication
by: Yasuhiko eYamamoto, et al.
Published: (2013-08-01)

The effect of guideline revisions on vascular complications of type 2 diabetes
by: Ralph Heijmans, et al.
Published: (2019-09-01)

Determinants of vascular complications in patients with type 2 diabetes mellitus.
by: Lee Ming-Chen, et al.
Published: (2006)

Study of the LMNA 1908 C/T gene polymorphism in type 2 diabetic Egyptians with vascular complications
by: Heba Mostafa, et al.
Published: (2015-01-01)

Assessment of plasma insulin, c-peptide, and blood pressure parameters of type 1 and type 2 diabetes mellitus and diabetic complications
by: Friday K. Iweka, et al.
Published: (2020-05-01)

Correlations between Glucagon Stimulated C-peptide Levels and Microvascular Complications in Type 2 Diabetes Patients
by: Hye-Jin Yoon, et al.
Published: (2012-10-01)

Subclinical hypothyroidism ups the risk of vascular complications in type 2 diabetes
by: Ghada A. Mohamed, et al.
Published: (2017-08-01)

Recent Updates on Vascular Complications in Patients with Type 2 Diabetes Mellitus
by: Chan-Hee Jung, et al.
Published: (2020-06-01)

Glycemic Variability and Vascular Complications in Patients with Type 2 Diabetes Mellitus
by: Caprnda Martin, et al.
Published: (2017-09-01)

Bilirubin levels determine vascular complications in diabetes mellitus type 2
Published: (2013-03-01)

Novel Approaches in the Management of Type 2 Diabetes and Associated Vascular Complications
by: K. V. S. Hari Kumar
Published: (2021-06-01)

Association between Serum Cystatin C and Vascular Complications in Type 2 Diabetes Mellitus without Nephropathy
by: Hye Jeong Kim, et al.
Published: (2018-10-01)

Cognition in type 2 diabetes: Association with vascular risk factors, complications of diabetes and depression
by: Iype Thomas, et al.
Published: (2009-01-01)

Letter: Diabetic Retinopathy and Endothelial Dysfunction in Patients with Type 2 Diabetes Mellitus ( 2013;37:262-9)
by: Seok Man Son
Published: (2013-10-01)

To study association of Neutrophil- Lymphocyte ratio with vascular complications in Type-2 Diabetes
by: Shilpa Tumkur Andane Gowda, et al.
Published: (2021-08-01)

Vascular complications of black patients with type 2 diabetes mellitus in Southern Brazil
by: F. Gerchman, et al.
Published: (2008-08-01)

Vascular complications of type 2 diabetes mellitus beyond the reach of glycemic control
by: Tatiana Yul'evna Demidova
Published: (2010-09-01)

The <it>CTGF</it> gene −945 G/C polymorphism is not associated with cardiac or kidney complications in subjects with type 2 diabetes
by: Patel Sheila K, et al.
Published: (2012-04-01)

N-terminal fragment of probrain natriuretic peptide is associated with diabetes microvascular complications in type 2 diabetes
by: Hamano K, et al.
Published: (2014-10-01)

Epigenetic Diabetic Vascular Complications
by: Ali Ahmadzadeh-Amiri, et al.
Published: (2016-01-01)

Chronic Vascular Complications in Diabetes
by: Weiping Jia, et al.
Published: (2013-01-01)

Epigenetic Diabetic Vascular Complications
by: Ali Ahmadzadeh-Amiri, et al.
Published: (2016-01-01)

Correlation of serum angiogenin level with various vascular complications in type 2 diabetic patients
by: Nagwa F. Ahmed, et al.
Published: (2012-01-01)

P.050 PREDICTIVE FACTORS FOR MACRO- AND MICRO-VASCULAR COMPLICATIONS IN TYPE 2 DIABETES
by: H. Rosolova, et al.
Published: (2007-08-01)

The effect of hyperglycemia and oxidative stress on the development and progress of vascular complications in type 2 diabetes
by: Čolak Emina, et al.
Published: (2009-01-01)

Type 1 and 2 Diabetes Mellitus: interference of vascular and neurological complications in occupational performance
by: Pâmela Bertazo Viêro, et al.
Published: (2017-03-01)

Increasing Vascular Complications Depends on The Duration Disease of Having Been Diabetic Type 2
by: Zahraa Majid Ismail, et al.
Published: (2020-08-01)

C-Peptide-Based Index Is More Related to Incident Type 2 Diabetes in Non-Diabetic Subjects than Insulin-Based Index
by: Jong-Dai Kim, et al.
Published: (2016-06-01)

Quantification of serum C-mannosyl tryptophan by novel assay to evaluate renal function and vascular complications in patients with type 2 diabetes
by: Shuhei Morita, et al.
Published: (2021-01-01)

Hemopoiesis indices in patients with diabetes type II with and without vascular complications
by: Bondar Т.Р., et al.
Published: (2010-12-01)

Proinsulin C-peptide: Friend or foe in the development of diabetes-associated complications?
by: Lina Nordquist, et al.
Published: (2008-12-01)

N-terminal fragment of probrain natriuretic peptide is associated with diabetes microvascular complications in type 2 diabetes [Corrigendum]
by: Hamano K, et al.
Published: (2014-11-01)

Associations between urinary 6‐sulfatoxymelatonin excretion and diabetic vascular complications or arteriosclerosis in patients with type 2 diabetes
by: Kenichi Tanaka, et al.
Published: (2021-04-01)

Study on the Risk Factors for Hyperuricaemia and Related Vascular Complications in Patients with Type 2 Diabetes Mellitus
by: Shi R, et al.
Published: (2020-09-01)

Endothelial cell dysfunction and the vascular complications associated with type 2 diabetes: assessing the health of the endothelium
by: Hong Ding, et al.
Published: (2005-04-01)

Association study of the plasma concentration of YKL-40 and vascular complications in patients with type 2 diabetes
by: Chih-Hung Lin, et al.
Published: (2011)

Functional Vascular Study in Hypertensive Subjects with Type 2 Diabetes Using Losartan or Amlodipine
by: Cesar Romaro Pozzobon, et al.
Published: (2014-07-01)

Biological Activity of c-Peptide in Microvascular Complications of Type 1 Diabetes—Time for Translational Studies or Back to the Basics?
by: Aleksandra Ryk, et al.
Published: (2020-12-01)